Skip to main content
Fig. 3 | BMC Pediatrics

Fig. 3

From: Effectiveness of BNT162b2 COVID-19 primary series vaccination in children aged 5–17 years in the United States: a cohort study

Fig. 3

Effectiveness of Receiving a Complete Primary Series of BNT162b2 by Variant Era. Note: Pre-Delta era, December 11, 2020, through May 31, 2021; Delta era, June 1, 2021, through December 24, 2021; Omicron era, December 25, 2021, through the end of data availability. CI = confidence interval; COVID-19 = coronavirus disease 2019; VE = vaccine effectiveness

Back to article page

BMC Pediatrics

ISSN: 1471-2431

Contact us